Abstract
To determine whether any strain specificity could be shown in freshly isolated hemolytic streptococci from erysipelas as compared with those from other sources, intradermal injections into rabbits were made with 10 strains from erysipelas, 10 from scarlet fever, 3 from acute abscesses, 2 from meningitis, and 5 stock strains, including 2 originally isolated from acute mastoiditis, and the scarlatinal strains NY 5 and Dick II, and erysipelas strain A I furnished by the New York City Department of Health Laboratories. The dosage was 0.02 of an emulsified 24-hour blood agar slant injected into the depilated skin of the back, 2 rabbits being tested with each strain. In no instance did a spreading erysipelas develop, the lesion produced being a localized reddened indurated swelling involving from one to 10 sq. cm., reaching its height on the second or third day, and subsiding slowly. Occasionally an abscess formed. The results are summarized in Table I.
Although the appearance of the lesion was identical with all organisms used, the strains from erysipelas produced slightly larger areas of skin involvement, the average size of the lesion produced by erysipelas strains being 3.55, that of scarlet fever strains 1.66, and that of the organisms from septic lesions 1.35 expressed as square centimeters. The stock strains used showed lesions similar in size and character to those produced by freshly isolated organisms from septic infections.
Three strains from scarlet fever and 3 from erysipelas used intradermally were each passed through 3 rabbits. After such passage the skin lesions produced by the erysipelas strains were of approximately the same size as before and averaged 4.5 sq. cm. Each of the scarlet fever strains was found to involve a larger skin area than previously, the average size being 4.8 sq. cm., or an increase to the size of the lesion resulting from the erysipelas organisms.
Get full access to this article
View all access options for this article.
